Commercial Services and Supplies
Company Overview of Mayo Clinic
Mayo Clinic is a not-for-profit organization that provides medical care, research, and education services. It offers medical care services in areas such as diabetes and endocrinology, gastroenterology, gynecology, neurophysiology, neurology and neurosurgery, orthopedics, pulmonology, rheumatology, nephrology, urology, and cardiology. The company also operates a network of care centers in the United States. Additionally, it provides medical education services through schools that offer degree and certificate programs in continuing medical education, doctoral, master’s, and health sciences. Further, the company conducts translational, clinical, and epidemiological research services. Furthermor...
200 First Street SW
Rochester, MN 55905
Founded in 1863
Key Executives for Mayo Clinic
Chairman of Board of Governors, Chief Executive Officer, President and Trustee
Vice President, Trustee and Chief Executive Officer of Mayo Clinic - Arizona
Vice President, Trustee, Member of Board of Governors and CEO of Mayo Clinic Florida
Chief Administrative Officer, Vice President of Administration and Trustee
Compensation as of Fiscal Year 2017.
Mayo Clinic Key Developments
AliveCor Inc. Enters into Agreement with Mayo Clinic
Jul 20 17
AliveCor Inc. has entered into an agreement with Mayo Clinic to develop tools for medical and non-medical personnel to easily screen for long QT syndrome (LQTS) early by combining AliveCor’s AI technology with Mayo Clinic’s patented algorithms. Through the agreement, new methods and techniques to detect LQTS will be developed for AliveCor’s Kardia mobile device, a device that is both portable and affordable. The agreement envisions a tool that will enable people to practice preventive medicine on an unprecedented scale and provide instantaneous results previously unavailable unless patients visited a doctor’s office. This agreement enables AliveCor and Mayo Clinic to develop ground breaking AI technology to help prevent sudden cardiac death.
Mayo Clinic and nference Form Joint Venture
Jul 17 17
Mayo Clinic and nference, Inc. have formed a joint venture for the drug development that will be powered by clinical expertise and artificial intelligence. The JV company was named as Qrativ, Inc. Concurrently, Qrativ has raised USD 8.3 million in series A venture financing round. The finance was provided by Matrix Capital Management Company, LLC, Matrix Partners and Mayo Clinic. The JV company will combine nference's AI-driven knowledge synthesis platform with Mayo Clinic's medical expertise and clinical data. Qrativ seeks to discover and develop treatments for diseases with unmet medical need. Pursuant to the agreement, Mayo Clinic and Andrew Badley have a financial interest in Qrativ. Mayo Clinic will use any revenue it receives to support its not-for-profit mission in patient care, education and research. This agreement enables Mayo Clinic and nference to develop treatments for diseases with unmet medical need.
Moleculin Biotech, Inc. Announces Research Agreement with Mayo Clinic for Pediatric Brain Tumor Study
Jun 26 17
Moleculin Biotech, Inc. has announced it has entered into an agreement with Mayo Clinic to enable additional research on Moleculin's WP1066 molecule for the possible treatment of a rare form of pediatric brain tumor. Mayo Clinic physician-scientists have requested and Moleculin has agreed to supply them with WP1066 for preclinical testing for the potential treatment of pediatric Diffuse Intrinsic Pontine Gliomas (DIPG), a rare and very aggressive form of brain tumor. Mayo Clinic studies have suggested that DIPG may be particularly sensitive to the inhibition of the activated form of a cell-signaling protein called STAT3, a primary target of WP1066, and their preliminary studies have demonstrated significant anti-tumor activity of WP1066 in DIPG in vitro and in vivo tumor models.
Similar Private Companies By Industry
Recent Private Companies Transactions